These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6545410)

  • 1. Endocrine changes and clinical profiles in depression: I. The dexamethasone suppression test.
    Calloway SP; Dolan RJ; Fonagy P; De Souza VF; Wakeling A
    Psychol Med; 1984 Nov; 14(4):749-58. PubMed ID: 6545410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature].
    Tajima-Pozo K; Montes-Montero A; Güemes I; González-Vives S; Díaz-Marsá M; Carrasco JL
    Endocrinol Nutr; 2013; 60(7):396-403. PubMed ID: 23623464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of the DST results in depressives by means of urinary-free cortisol excretion, dexamethasone levels, and age.
    Maes M; Jacobs MP; Suy E; Minner B; Raus J
    Biol Psychiatry; 1990 Aug; 28(4):349-57. PubMed ID: 2397250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma ACTH levels in primary depression: relationship to the 24-hour dexamethasone suppression test.
    Yerevanian BI; Woolf PD
    Psychiatry Res; 1983 May; 9(1):45-51. PubMed ID: 6310664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone suppression test by measuring spot urinary free cortisol in depression.
    Tomitaka S; Sakamoto K; Tamura A; Kojima I; Fujita H
    Biol Psychiatry; 1996 Feb; 39(3):220-2. PubMed ID: 8837985
    [No Abstract]   [Full Text] [Related]  

  • 6. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
    Carson SW; Halbreich U; Yeh CM; Asnis G; Goldstein S
    Biol Psychiatry; 1988 Sep; 24(5):569-77. PubMed ID: 3167145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma ACTH and cortisol concentrations before and after dexamethasone.
    Kalin NH; Weiler SJ; Shelton SE
    Psychiatry Res; 1982 Aug; 7(1):87-92. PubMed ID: 6291080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Life events, depression and hypothalamic-pituitary-adrenal axis function.
    Dolan RJ; Calloway SP; Fonagy P; De Souza FV; Wakeling A
    Br J Psychiatry; 1985 Oct; 147():429-33. PubMed ID: 4075033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet MAO activity and the cortisol response to dexamethasone in major depression.
    Meltzer HY; Lowy MT; Locascio JJ
    Biol Psychiatry; 1988 Jun; 24(2):129-42. PubMed ID: 3390495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent elevation of urinary free cortisol and loss of circannual periodicity in recovered depressive patients. A trait finding.
    Kathol RG
    J Affect Disord; 1985; 8(2):137-45. PubMed ID: 3157722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dexamethasone suppression and metyrapone tests in depression.
    Morphy MA; Fava GA; Perini GI; Molnar G; Zielezny M; Lisansky J
    Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrodermal activity in relation to cortisol dysregulation in depressive patients.
    Thorell LH; Kjellman BF; d'Elia G; Kågedal B
    Acta Psychiatr Scand; 1988 Dec; 78(6):743-53. PubMed ID: 3223333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone suppression test in depression: association with duration of illness.
    Sashidharan SP; Freeman CP; Loudon JB; Novosel S; Beckett GJ; Gray S
    Acta Psychiatr Scand; 1984 Oct; 70(4):354-60. PubMed ID: 6496159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward an understanding of cortisol dysregulation in major depression: a review of studies of the dexamethasone suppression test and urinary free-cortisol.
    Reus VI
    Psychiatr Med; 1985; 3(1):1-21. PubMed ID: 3037609
    [No Abstract]   [Full Text] [Related]  

  • 15. The dexamethasone suppression test in affective disorder: relationship to clinical and genetic subgroups.
    Mendlewicz J; Charles G; Franckson JM
    Br J Psychiatry; 1982 Nov; 141():464-70. PubMed ID: 7150882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic-pituitary-adrenal axis activity and tricyclic response in major depression.
    Nelson WH; Orr WW; Stevenson JM; Shane SR
    Arch Gen Psychiatry; 1982 Sep; 39(9):1033-6. PubMed ID: 7115012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPA axis dysregulation in men with hypersexual disorder.
    Chatzittofis A; Arver S; Öberg K; Hallberg J; Nordström P; Jokinen J
    Psychoneuroendocrinology; 2016 Jan; 63():247-53. PubMed ID: 26519779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone suppression test in alcoholism.
    Abou-Saleh MT; Merry J; Coppen A
    Acta Psychiatr Scand; 1984 Feb; 69(2):112-6. PubMed ID: 6702473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of stress on the dexamethasone suppression test.
    Ceulemans DL; Westenberg HG; van Praag HM
    Psychiatry Res; 1985 Mar; 14(3):189-95. PubMed ID: 3858891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone suppression test in relation to symptomatology: preliminary findings controlling for serum dexamethasone concentrations.
    Smith J; Carr V; Morris H; Gilliland J
    Psychiatry Res; 1988 Aug; 25(2):123-33. PubMed ID: 3174902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.